In Silico Screening and Molecular Docking of Phytochemicals Against SARS-Cov-2 Main Protease: Prioritizing Leads For In Vitro Testing
Drug Discovery and Molecular Docking (DDMD) · 18.12.2025 · 1 (3) · 15-25
DOI: 10.64474/3107-6688.vol1.issue3.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discovery and Molecular Docking (DDMD), online erschienen am 18.12.2025. Verfasst von Aishwarya Jhala und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jhala, A., Raghuvanshi, U., & Gupta, N. (2025). In Silico Screening and Molecular Docking of Phytochemicals Against SARS-Cov-2 Main Protease: Prioritizing Leads For In Vitro Testing. Drug Discovery and Molecular Docking (DDMD), 1(3), 15-25. https://doi.org/10.64474/3107-6688.vol1.issue3.2
Vancouver
Jhala A, Raghuvanshi U, Gupta N. In Silico Screening and Molecular Docking of Phytochemicals Against SARS-Cov-2 Main Protease: Prioritizing Leads For In Vitro Testing. Drug Discovery and Molecular Docking (DDMD). 2025;1(3):15-25. doi:10.64474/3107-6688.vol1.issue3.2
BibTeX
@article{Jhala2025,
author = {Jhala, Aishwarya and Raghuvanshi, Urmila and Gupta, Nitish},
title = {In Silico Screening and Molecular Docking of Phytochemicals Against SARS-Cov-2 Main Protease: Prioritizing Leads For In Vitro Testing},
journal = {Drug Discovery and Molecular Docking (DDMD)},
year = {2025},
volume = {1},
number = {3},
pages = {15--25},
doi = {10.64474/3107-6688.vol1.issue3.2}
}
EUVIMED